IBC3:F:F-iShares Core MSCI EM IMI UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 4.5812

Change

+0.03 (+0.71)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.18 (+0.65%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.41 (+0.80%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

+3.44 (+0.63%)

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.73 (-1.29%)

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.40 (+0.17%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.15 (+0.98%)

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.20 (+0.21%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.17 (+0.17%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

+0.76 (+0.50%)

USD 37.92B

ETFs Containing IBC3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.80% 66% D+ 65% D
Dividend Return 2.72% 21% F 35% F
Total Return 15.52% 70% C- 61% D-
Trailing 12 Months  
Capital Gain 17.67% 56% F 62% D
Dividend Return 2.84% 16% F 29% F
Total Return 20.51% 62% D 57% F
Trailing 5 Years  
Capital Gain 22.61% 45% F 55% F
Dividend Return 2.96% 44% F 9% A-
Total Return 25.57% 47% F 44% F
Average Annual (5 Year Horizon)  
Capital Gain 3.38% N/A N/A 54% F
Dividend Return 3.50% N/A N/A 48% F
Total Return 0.12% N/A N/A 5% F
Risk Return Profile  
Volatility (Standard Deviation) 15.06% N/A N/A 76% C+
Risk Adjusted Return 23.22% N/A N/A 51% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike